Concepedia

Moataz Reda

MR

Statistics

Publications

12

Citations

868

H-Index

11

Active since

2015

Affiliations

Oregon Health & Science University(Current)

PDX Pharmaceuticals (United States)

Moataz Reda is an author at Oregon Health & Science University specializing in nanomedicine, nanoparticle drug delivery, and pharmacy.

Publications per year

2015–2022

12

Publications

12

Cationic Polymer Modified Mesoporous Silica Nanoparticles for Targeted siRNA Delivery to HER2<sup>+</sup> Breast Cancer

Worapol Ngamcherdtrakul, Jingga Morry, Shenda Gu et al. · Advanced Functional Materials · 2015 · 190 citations · Full text

, , +17

Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment

Moataz Reda, Worapol Ngamcherdtrakul, Molly A. Nelson et al. · Nature Communications · 2022 · 189 citations · Full text

, , +17

PLK1 and EGFR targeted nanoparticle as a radiation sensitizer for non-small cell lung cancer

Moataz Reda, Worapol Ngamcherdtrakul, Shenda Gu et al. · Cancer Letters · 2019 · 73 citations · Full text

, , +14

In Situ Tumor Vaccination with Nanoparticle Co‐Delivering CpG and STAT3 siRNA to Effectively Induce Whole‐Body Antitumor Immune Response

Worapol Ngamcherdtrakul, Moataz Reda, Molly A. Nelson et al. · Advanced Materials · 2021 · 73 citations · Full text

, , +17

Dermal delivery of HSP47 siRNA with NOX4-modulating mesoporous silica-based nanoparticles for treating fibrosis

Jingga Morry, Worapol Ngamcherdtrakul, Shenda Gu et al. · Biomaterials · 2015 · 70 citations

, , +16

1–5 of 12